Načítá se...
Lessons learned from peginesatide in the treatment of anemia associated with chronic kidney disease in patients on dialysis
Peginesatide is the newest erythropoietin-stimulating agent (ESA) in the quest for the ideal treatment of anemia in chronic kidney disease (CKD) patients. Reduced frequency of administration along with a possibly lower cost as a result of simpler manufacturing techniques compared with other availabl...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3848525/ https://ncbi.nlm.nih.gov/pubmed/24348017 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S34935 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|